Treatment with Lopinavir/Ritonavir in Heavily Pretreated Subjects Failing Multiple Antiretroviral Regimens in Clinical Practice
- 1 August 2002
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 30 (5) , 533-535
- https://doi.org/10.1097/00126334-200208150-00010
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Identification of Genotypic Changes in Human Immunodeficiency Virus Protease That Correlate with Reduced Susceptibility to the Protease Inhibitor Lopinavir among Viral Isolates from Protease Inhibitor-Experienced PatientsJournal of Virology, 2001
- Efficacy and safety of twice daily first-line ritonavir/indinavir plus double nucleoside combination therapy in HIV-infected individualsAIDS, 2000
- ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus ProteaseAntimicrobial Agents and Chemotherapy, 1998